R Squared’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16K Sell
11,276
-2,703
-19% -$2.49K ﹤0.01% 477
2025
Q4
$30.8K Buy
13,979
+3,356
+32% +$5.4K 0.01% 481
2025
Q3
$16.9K Sell
10,623
-4,277
-29% -$5.55K 0.01% 532
2025
Q2
$24.1K Buy
+14,900
New +$24.1K 0.01% 435

Other funds holding GUTS

R Squared's GUTS Position: Q1 2026 in Review

R Squared reduced its Fractyl Health (GUTS) stake by 19% in Q1 2026, selling an estimated $2.49K and leaving 11,276 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

R Squared first reported a position in GUTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $30.8K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • R Squared held 11,276 shares of Fractyl Health worth $5.16K as of Q1 2026.
  • R Squared sold 2,703 Fractyl Health shares in Q1 2026, an estimated $2.49K.
  • Fractyl Health made up ﹤0.01% of R Squared's portfolio in Q1 2026, its #477 holding.
  • R Squared first reported a position in Fractyl Health in Q2 2025 and has held it in 4 quarters since.
  • R Squared's Fractyl Health position peaked at $30.8K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.